Published on
Dec 31, 2024
Advancing Lung Cancer Treatment With Bispecific Antibodies: A Review of Amivantamab and Tarlatamab
About the Author Douglas Braun, PharmD, RPh, CSP, is a senior pharmacy director at American Oncology Network, LLC, in Fort Myers, Florida. Bispecific antibodies (BsAbs) are a class of antibodies that can bind to 2 different sites at the same time. They are …
Source:
Pharmacy Times
-
Neutral
